Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
XOMA (US) LLC
A phase II, randomized, double-blind, placebo-controlled study to: 1. Demonstrate the clinical efficacy of efalizumab in the treatment of subjects with psoriatic arthritis (PsA). 2. Evaluate the safety, tolerability and pharmacokinetics of efalizumab in the treatment of subjects with PsA
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted